Medications
13 scheduled Β· ~23 PRN. Heavy but coherent once foundational history is folded in (AFib + Watchman, Tourette's, mini-stroke) β and a touch lighter after the 6/8 update: Vistaril off, trazodone stopped, losartan added for BP.
Last full reconciliation 2026-06-08 per NP Alyssa (The Recovery Team) β call notes. BP regimen changed after a mid-June ER visit (med-change copy pending) β see Current meds. Baseline: Haven Doctor's Orders PDF, 2026-05-26 (original PDF β).
π New: the October 2025 pre-crisis baseline, reconciled against today β corrects what olanzapine and the cardiac block actually are, surfaces a ventricular-arrhythmia history, and reframes the tic story.
π New: the CVS pharmacy pull (2026-06-16) β full med β prescriber map (surfaced his Apollo Beach doctors), what's active vs. lapsing vs. removed, and the doses that differ from this list.
At a glance
π« Cardiovascular (6 scheduled)
Post-Watchman + post-stroke + CAD + HTN Β· BP 150β160 (post-ER under-dosing fix)
- Aspirin 81 mg AM
- Clopidogrel 75 mg AM
- Atorvastatin 40 mg HS
- Metoprolol 50 mg BID
- Amlodipine 5 mg AM
- Losartan 25 mg β new 6/8 β BP trial
Clonidine 0.1 mg BID PRNβ taper done 5/30
π§ Psychiatric scheduled (3)
Tourette's Β· nerve pain + mood
- Olanzapine 10 mg HS β Tourette's (was: mood)
- Duloxetine 40 mg BID (80 mg/day) β nerve pain + mood (was: depression; not a tic drug)
- NAC 300 mg AM β inflammation (was: tics); tics still under-covered per Dad (5/27) β push dose escalation + neuro consult
π΄ Sleep stack (4 active)
Lightened 6/8 β consolidation underway
- Melatonin 5 mg HS β scheduled
- Olanzapine 10 mg HS
Trazodone 50 mg HS PRNβ stopped (unused >1 wk)Vistaril 50 mg q6h PRNβ discontinued 6/8- Valerian 500 mg PRN
- Passion flower 1500 mg PRN
Two agents down from the 6/8 update β good direction off the fall-risk cocktail.
π§΄ GI
Pantoprazole + ~10 PRN agents
- Pantoprazole 40 mg AM β unchanged (confirmed 6/8)
- PRN: Mylanta, Pepto, Miralax, Colace, Loperamide
- PRN: Dicyclomine, Calcium carbonate, Milk of Magnesia
- PRN: Ondansetron PO + IM
π€ Pain
Non-opioid path
- Lidocaine 4% patch nightly PRN β back pain
- Acetaminophen 500 mg q6h PRN
- Ibuprofen 200 mg PRN β bleed risk on DAPT, prefer acetaminophen
π Supplements
Standard substance-use protocol
- Multivitamin
- Thiamine 100 mg AM β Wernicke's prophylaxis
- Vitamin C 500 mg PRN
Detailed breakdown
Per-drug concerns + monitoring asks live in the legacy detail page, kept for now while we polish the new template.
π Open questions for the care team
Priority-ordered, most safety-critical first. Answered items are greyed at the bottom.
- Kindling prophylaxis: still no gabapentin (or other anticonvulsant) in the regimen. The load-bearing safety ask given his kindling vulnerability β flagged 4+ sessions. Why not?
- A dedicated tic med is sitting unused: Oct 2025 lists haloperidol 0.5 mg "Treat Tourette's" β prescribed but not taken. With Xanax (the de facto tic suppressant) gone and tics now at self-injury (raw tongue), the tic regimen needs to be built intentionally β neuro referral + a modern agent (aripiprazole / VMAT2) + CBIT + botox for the tongue tic.
- BP β 150β160 after the mid-June under-dosing fix. Ran 160+ and triggered the crisis; TRT found his BP meds under-dosed, the ER stabilized him, and it's run 150β160 since (still elevated). On amlodipine + metoprolol + losartan. Get the resulting med-change copy. Is duloxetine (raises BP) contributing? Recheck cadence + threshold to escalate?
- Amlodipine was halved since Oct 2025: 10 β 5 mg. Did cutting it feed the BP elevation? Revisit alongside the losartan trial.
- Ventricular arrhythmia history (Oct 2025 baseline): amiodarone was prescribed for ventricular arrhythmias (stopped over vision problems) β deeper than the AFib we'd documented. Confirm with cardiology; it raises the QT stakes on olanzapine + duloxetine + any tic antipsychotic.
- EKG on file? Likely from April ER admission. Confirm + repeat cadence on olanzapine (QT baseline β ties to the arrhythmia history above).
- Watchman implant date: determines when DAPT steps down to aspirin alone.
- Discontinuation roadmap for olanzapine + duloxetine.
- MOUD path: no buprenorphine / naltrexone visible. Long-acting naltrexone (Vivitrol) before IOP.
- Bipolar screen given Baker Act + SNRI start.
- Quetiapine vs olanzapine trade given the metabolic baseline.
- NAC dose escalation: 300 mg/day is sub-research (600β1200 mg BID for tics + craving).
- Vascepa (icosapent ethyl) evaluation (high SCD-risk omega + TG 237 + CAD).
- Lp(a) β missing from 2025 baseline.
- DEXA scan: baseline for the osteoporosis vector.
- Sleep stack consolidation roadmap for Phase 2.
- Ketamine / Spravato if duloxetine doesn't land within 6β8 weeks.
- ADHD + migraine dropped: Quelbree (viloxazine, ADHD) and Nurtec (rimegepant, migraine) were both active Oct 2025 and are gone now. Re-address if symptoms return.
- Allergies β verified on file. Aspirin (historical, tolerated post-CABG), epinephrine (not a true allergy), shellfish (anaphylactic, cardiac-arrest history).
- GeneSight (CYP2D6) for duloxetine β back. CYP2D6 intermediate β duloxetine runs high (don't escalate; lower or switch β Pristiq bypasses CYP2D6). Also UGT2B15 poor (Ativan/oxazepam accumulate; Xanax/Klonopin gene-clean). Full read β
- CYP2C19 PGx for clopidogrel β answered. CYP2C19 ultrarapid (*17/*17) β activates clopidogrel fully, not a non-responder. Share with cardiology. GeneSight β